Chaitanya Kankanala | Sr. Engineer
Sanofi

Chaitanya Kankanala, Sr. Engineer, Sanofi

Chaitanya Kankanala is a Senior mRNA Engineer in Process Development for Vaccines at Sanofi, based in Waltham, MA. He works within the Early Development Pilot Lab, focusing on advancing mRNA vaccine process development from early-stage research to scalable manufacturing. His work supports Sanofi's mission to bring innovative vaccine technologies to patients worldwide.

Appearances:



Festival of Biologics Day 2 @ 15:00

Accelerating mRNA Purification Process Development Through Mechanistic Modeling of Oligo-dT Chromatography

OligodeoxyThymidine (Oligo-dT) affinity chromatography can be used for mRNA purification, exploiting poly-A tail binding to remove impurities. However, process variability and construct-size-dependent behavior challenge yield optimization and GMP consistency. Mechanistic modeling offers data-driven approach to these challenges and accelerate process understanding.

 

Model calibration achieved R²≥0.95 for UV fit, with <1% parameter error for the target mRNA and <5% for fragments across experiments. Three optimization strategies were evaluated using the calibrated model: (1) Wash Strategy: in silico simulations of GMP wash step matched experimental data, validating predictive fidelity; (2) Dynamic Binding Capacity (DBC) Strategy: simulations revealed steric exclusion of larger constructs from internal pores, with increased load residence time significantly improving binding; (3) Buffer Optimization: screening identified elution conditions that reduced variability and improving pH stability. Model-guided optimization enabled mechanistic understanding of the process, reducing empirical experimentation for wash step evaluation, DBC enhancement, and buffer optimization. This framework accelerates process development, improves product quality, and supports platform-level mRNA manufacturing decisions.

 

This work was previously presented at the 5th mRNA Process Development & CMC Summit 2026 held in Boston (MA), Sep 30- Oct 1, 2026.

 

This work was funded by Sanofi.

All authors are or were Sanofi employees and may hold shares or stock options in the company.

last published: 18/Nov/26 17:29 GMT

back to speakers

Get involved at Festival of Biologics USA 2027

 

 

TO SPONSOR


Nicholas Matthews

Nicholas.Matthews@terrapinn.com

 

 

TO SPEAK


Jack Beard
Jack.Beard@terrapinn.com

 

MARKETING & PRESS


Ollie McDaid

Ollie.Mcdaid@terrapinn.com

 

Stay Up-to-Date

Join our mailing list to receive exclusive content and offers.

By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.